Selvita S.A. Company Profile

07:39 EDT 24th March 2018 | BioPortfolio

Selvita delivers comprehensive solutions to customers from the pharmaceutical and biotechnology industry targeted at speedy and cost-effective introduction of efficacious and safe drugs to the market.

The areas of our activity include:

  • Research on new chemical entities originating from Polish universities or resulting from Selvita's own discovery programs
  • Integrated fee-for-service drug discovery projects based on medicinal chemistry, biology and pharmacology services
  • Target-based solutions - advanced protein modeling solutions
  • Drug discovery  - custom in-silico library construction
  • Lead generation - optimization of lead compounds
  • Contract synthesis and syntheses paths optimization
  • Information technology for research projects

Selvita is also the majority shareholder of BioCentrum (, which provides preclinical ADMET services, and biopharmaceutical development services. Selvita Group laboratories have the General Pharmaceutical Inspectorate accreditation and Good Laboratory Practice (GLP) certification.

Selvita develops its own innovative drugs, which originate from research at Polish universities and later commercializes them with partners from the pharmaceutical industry. Selvita is involved in several research projects at the pre-clinical stage. Our current projects are in the area of oncology and central nervous system.

We employ over 160 top-class professionals from the area of medicine, chemistry, pharmacy, molecular biology, biotechnology and informatics, and almost 40% of Selvita employees hold a PhD degree in the field of biomedical research.  Many of our experts have several years of experience in the biotechnology and pharmaceutical companies in the U.S., Canada, UK, Germany and Poland, and publications in the best scientific journals such as: Nature Biotechnology, Science, and the Journal of Medicinal Chemistry. We work with leading universities and research centers from Poland, Europe and United States.
In our work we adhere to the highest ethical standards, both in dealing with the environment and within the company. Our goal is to develop solutions that contribute to the extension and improvement of the quality of life. In doing so, Selvita is guided by the respect for human life at it's every stage, and does not conduct research which violates human dignity.


Park Life Science
ul. Bobrzyńskiego 14,


Phone: +48 12 297 47 00
Fax: +48 12 297 47 01

News Articles [19 Associated News Articles listed on BioPortfolio]

BRIEF—Selvita names MorphoSys exec as chief medical officer

Poland’s leading biopharma company Selvita today announced the appointment of Steffen Heeger to the…

Selvita (SLV) - Phase I/II with SEL24 to continue

Edison Investment Research - Pharmaceutical & healthcare - Selvita: On 16 December 2017, Selvita announced that the FDA had lifted the clinical hold on the Phase I/II clinical trial with the company&r...

Promotion at Poland’s Selvita

The Supervisory Board of Selvita has appointed Edyta Jaworska to the position of a management board member,…

Selvita completes near $41 million book building

Polish biotech firm Selvita pleased investors with its announcement of a major share 2.2 million placement,…

Selvita (SLV) - New 2017-2021 strategy to boost R&D

Edison Investment Research - Pharmaceutical & healthcare - Selvita: Selvita offers a two-pronged strategy with steady double digit growth from its drug discovery business coupled with potential upside...

Poland’s Selvita aims to raise ~$40 million in public offering

Poland’s leading biotech firm Selvita has confirmed its intention to conduct a secondary public offering.

Selvita to cash in €90m in Menarini deal

Selvita appoints Dr Steffen Heeger as Chief Medical Officer

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]

Selvita S.A.

Selvita delivers comprehensive solutions to customers from the pharmaceutical and biotechnology industry targeted at speedy and cost-effective introduction of efficacious and safe drugs to the marke...

More Information about "Selvita S.A." on BioPortfolio

We have published hundreds of Selvita S.A. news stories on BioPortfolio along with dozens of Selvita S.A. Clinical Trials and PubMed Articles about Selvita S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selvita S.A. Companies in our database. You can also find out about relevant Selvita S.A. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record